Significant benefits seen in drug use, pain, depression, treatment retention, and adherence

No significant benefits seen for most measures of utilization, quality, outcomes

Increases in glucocorticoids in response to the Trier Social Stress Test were common for women using hormonal contraceptives

Effects most strongly seen in those working night shifts

FDA is investigating reports of hair loss, aspiration, and suicidal thoughts among people taking the medications

Adverse physiologic effect exposure rate highest for increased drug concentrations, CNS depression, QT interval prolongation

Gender differences seen in prevalence, timing, and most common mental disorders

Women in second and third versus first tertile of psychological stress have higher probabilities of having abnormal glucose during pregnancy

Improvements seen in parental, pediatric, and family psychosocial outcomes; more efficient for parents of children aged 10 years or younger

Novel treatment protocol shows response rate of two-thirds